Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hurthle Cell Carcinoma.

Grossman1, Clark

  • 1Department of Surgery, University of California, San Francisco/Mount Zion Medical Center 94115, USA.

Cancer Control : Journal of the Moffitt Cancer Center
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Filling Teeth.

The Dental register·2021
Same author

Observations on the Ergot of Rye.

The London medical and physical journal·2018
Same author

Confirmation of complete colonoscopy without intubation of the ileum.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2013
Same author

Dr. Ranking's Inquiries: On Cod-Liver Oil in Phthisis.

Provincial medical & surgical journal·2010
Same author

RESPONSE: Re: Tumor Characteristics and Clinical Outcome of Elderly Women With Breast Cancer.

Journal of the National Cancer Institute·2001
Same author

Changing surgical approaches to patients with primary hyperparathyroidism.

Current surgery·2000

Hurthle cell carcinoma, a rare thyroid cancer, presents diagnostic challenges and aggressive behavior. Total thyroidectomy with central neck dissection is recommended for optimal treatment outcomes.

Area of Science:

  • Endocrinology
  • Oncology
  • Surgical Pathology

Background:

  • Hurthle cell carcinoma accounts for approximately 3% of differentiated thyroid cancers.
  • Distinguishing Hurthle cell carcinoma from benign tumors can be challenging, impacting treatment strategies.
  • Optimal management for Hurthle cell carcinoma remains an area of ongoing clinical debate.

Purpose of the Study:

  • To review the current literature on Hurthle cell carcinoma presentation, behavior, and treatment.
  • To summarize the authors' clinical experience with Hurthle cell carcinoma patients.
  • To establish evidence-based recommendations for Hurthle cell carcinoma management.

Main Methods:

  • Comprehensive literature review of published studies on Hurthle cell carcinoma.

Related Experiment Videos

  • Retrospective analysis of 14 patients diagnosed with Hurthle cell carcinoma.
  • Evaluation of disease presentation, biologic characteristics, and treatment outcomes.

    • Main Results:

    • Hurthle cell carcinoma typically produces thyroglobulin but shows limited radioactive iodine uptake.
    • The cancer frequently presents as bilateral or multifocal disease with local invasion.
    • High rates of locoregional recurrence and significant patient mortality are associated with Hurthle cell carcinoma.

    Conclusions:

    • Total thyroidectomy is the preferred surgical approach for Hurthle cell carcinoma.
    • Central neck dissection should be performed concurrently with thyroidectomy.
    • This combined surgical approach is advocated as the treatment of choice for Hurthle cell carcinoma.